fashion -WSS

fashion

author：hotspot 2025-10-01 21:47:54 - browse：31641

Photo illustration of Stephen HEMSLEY -- UnitedHealth coverage from STAT — Stephen Hemsley, chair of the board and former chief executive officer of UnitedHealth Group Inc. Photo illustration: Alex Hogan; Source: AP

Stephen Hemsley, the former CEO of UnitedHealth Group and its current board chair, also owns an investment firm that manages his own portfolio of UnitedHealth stock and oversees other wealthy individuals’ accounts that have held shares of companies that have direct business with or indirect ties to United.

It’s an unusual arrangement for someone in such a prominent role at one of the largest health care corporations in the world, according to several experts in securities and corporate law interviewed by STAT, and one that they said highlights shortcomings in government disclosure requirements and raises concerns about potential conflicts of interest.

The arrangement is perfectly legal. But while other board chairs at large publicly traded health care companies, like Thomas Frist III at HCA Healthcare, hold high-ranking titles in the investment world, none were longtime chief executives of the same company they chair, like Hemsley. UnitedHealth also does not disclose Hemsley’s investment firm ownership to its shareholders in regular disclosures.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Readout LOUD podcast: mifepristone case, GLP

explore

WSS

FDA's naming rule on biosimilars has undermined competition

When women are denied an abortion, their children fare worse than peers

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Scientists boost immune system in aging mice by making it youthful

Readout Newsletter: Merck, Vertex, and Viking updates

hotspot

fashion

explore

Medicare details structure of new drug price negotiation program

Patient advocates debate FDA's accelerated approval process

Walensky prepares to leave CDC — and Congress — behind

Decaf coffee targeted by food safety group under obscure FDA rule

At least 13 dead in Texas as scorching temps continue

Stroke deaths set to near 10 million globally by 2050

In Memoriam: Notable people who died in 2023

3 questions for the future of Biden's cancer moonshot

What does generative AI mean for health care? We asked experts

A virus, fished out of a lake, may have saved a man’s life

knowledge

FDA authorizes Novavax’s updated Covid

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Bristol 'take

Sana to lay off nearly a third of staff, de

Eliminate the waiting period for sterilization covered by Medicaid

Decaf coffee targeted by food safety group under obscure FDA rule

leisure time

explore

explore

entertainment